Results 61 to 70 of about 432,885 (215)

Advances in the systemic therapy of malignant pleural mesothelioma.

, 2008
Malignant pleural mesothelioma is an aggressive thoracic malignancy associated with exposure to asbestos, and its incidence is anticipated to increase during the first half of this century.
Fennell, D. A., Van Meerbeeck, Jan, O'BYRNE, KJ, van Meerbeeck, J., Dean A Fennell, O'Byrne, Kenneth J., Gaudino, G., Luciano Mutti, Kenneth J O'Byrne, Giovanni Gaudino, MUTTI, L, Mutti, L., GAUDINO, G, Jan van Meerbeeck, FENNELL, DA, Fennell, Dean   +15 more
core   +1 more source

The Radiology Characteristic of Pleural Thickening Lesion: Mesothelioma Compared to the Other Pleural Diseases

Mutiara Medika, 2018
Mesothelioma is a malignancy pleural mass characterized by pleural thickening, that difficult to distinguish from other pleural disorders, such as infection, asbestosis, pleural effusion/empyema.
Ana Majdawati
doaj   +1 more source

Nucleolin and nucleophosmin expression patterns in pulmonary adenocarcinoma invading the pleura and in pleural malignant mesothelioma

Thoracic Cancer, 2020
Background Visceral pleural invasion (VPI) in adenocarcinoma of the lung is considered a poor prognostic factor. The purpose of this study was to analyze nucleolin and nucleophosmin expression in pulmonary adenocarcinoma (PA) with VPI and in pleural ...
Marek Masiuk, Piotr Waloszczyk, Magdalena Lewandowska, Ewa Dobak, Elzbieta Urasinska   +4 more
doaj   +1 more source

Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

Hepatology Research, Volume 56, Issue 11, Page 1614-1631, November 2026.
We carried out proteomic analysis of serum extracellular vesicles to identify biomarkers predictive of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B receiving nucleos(t)ide analog therapy. Candidate proteins identified through proteomic analysis were subsequently quantified in serum by ELISA.
Emi Sometani, Kazuhiro Murai, Hayato Hikita, Jihyun Sung, Satoshi Muraoka, Hidenori Toyoda, Satoshi Tanaka, Takayuki Miyake, Shinji Kuriki, Kenji Fukumoto, Satoshi Shigeno, Yuta Myojin, Kazuki Maesaka, Kumiko Shirai, Yuki Makino, Yuki Tahata, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori, Jun Adachi, Tomomi Yamada, Tetsuo Takehara   +21 more
wiley   +1 more source

Malignant pleural mesothelioma: when is radiation therapy indicated?

, 2011
Malignant pleural mesothelioma is an aggressive tumor of serosal surfaces resistant to many current treatment options. This article will provide a comprehensive discussion of the latest developments in the treatment of malignant pleural mesothelioma ...
Surmont, Veerle, Veerle F Surmont, Van Meerbeeck, JanUGent000070300950801001675834977419907185F9F55C2E-F0ED-11E1-A9DE-61C894A0A6B4, Van Meerbeeck, Jan, Eric RE van Thiel, Surmont, VeerleGE35UZGent8020014288650009-0000-4384-1908BEDF0802-85E8-11E2-9124-6A9010BDE39D, van Thiel, ERE, Jan P van Meerbeeck   +7 more
core   +1 more source

Simultaneous tongue metastasis from malignant pleural mesothelioma: Case report and literature review

Thoracic Cancer, 2021
Malignant pleural mesothelioma (MPM) is a rare neoplasm of the serosal membranes. MPM usually manifests as local invasion, rarely with distant haematogenous metastases in different organs. Few cases of tongue metastasis have been documented.
Chuan Huang, Xue Yang
doaj   +1 more source

Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion

Exploration, Volume 6, Issue 5, October 2026.
Over the past decades, chimeric antigen receptor (CAR)‐T cell therapy has evolved from a linear engineering concept into a powerful yet constrained immunotherapy, limited by tumour microenvironment barriers, immune evasion, and manufacturing complexity.
Yuesong Bai, Jintao Qin, Zongjun Dai, Ran Yan, Yong Yang, Wenguang Wang   +5 more
wiley   +1 more source

Malignant Pleural Mesothelioma: Surgical Management

, 2014
Malignant Pleural Mesothelioma: Surgical Management Presentation: 41 ...
Flores, MD, Raja M.
core   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

International Journal of Cancer, Volume 159, Issue 7, Page 1588-1601, 1 October 2026.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley, Liesbet J. Van Eycken, Meredith E. Giuliani, Brian A. Rous, Shao Hui Huang, Hisao Asamura, Mary K. Gospodarowicz, Anne W. Lee, Brian O'Sullivan   +8 more
wiley   +1 more source

Malignant pleural effusion: Relationship between thoracoscopic findings and type of malignancy

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Background: Pleural malignancy either primary or due to metastatic involvement can be presented by different macroscopic appearances in thoracoscopic examination of pleural cavity.
A.M. Abumossalam, T.T. Abdelgawad, A.M. Shebl   +2 more
doaj   +1 more source